TIMP 3 is a member of a group of proteins that inhibit matrix metalloproteinases and thereby prevent the degradation of the extracellular matrix. TIMP 3 has a high affinity for binding the extracellular matrix. An over expression of TIMP 3 may inhibit cancer cells and tumors in certain types of cancer, including prostate cancer.
Swiss-Prot Accession Number: P35625
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2025 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.